Professional Documents
Culture Documents
stool samples)
• 100,000 deaths/yr
• 50 million cases/yr
EPIDEMIOLOGY
India
• 15% prevalence (3.6-47.4%)
• Agent
• Virulence factor
• Host factor
• Environmental factor
• Mode of transmission
• Incubation period
AGENTS
• Entamoeba histolytica
Trophozoites
• 18-40 μm in D
• Cytoplasm – outer clear ectoplasm
inner granular endoplasm
food vacuoles with RBCs, leukocytes & tissue
debris
• Motile by pseudopodia extensions
• Nucleus with central karyosome, surrounded by delicate membrane lined
with chromatin granules
• Non infectious
AGENTS
• Entamoeba histolytica
Precyst
• Intermediate form
• Oval with blunt pseudopodia
• No food vacuoles
Cysts
• Spherical, 10 - 15 μm in D
• Uninucleate, later bi- or quadri- nucleate
• Thick chitinous wall
• Glycogen mass – not in quadrinucleate
• Chromidial or Chromatoid bars
• Infectious
INVASIVE X NONINVASIVE STRAINS
• 2- 4 weeks
LIFE CYCLE OF E. HISTOLYTICA
LIFE CYCLE OF E. HISTOLYTICA
CLINICAL PRESENTATION
• Most common type of amoebic infection is asymptomatic
cyst passage
• Intestinal amoebiasis – abdominal cramps with mild
diarrhea to colitis and dysentery
• Extra-intestinal amoebiasis – Amoebic liver abscess,
rarely lungs, skin, genitalia and CNS are affected
• Amoeboma – inflammatory and edematous reaction
around trophozoites
CLINICAL PRESENTATION
• Asymptomatic carriers
• Amoebic colitis-
• Abdominal cramp to severe pain
• Fever, vomiting, anorexia
• Mucus in stool, dysentery
• Flask shaped ulcer in intestine
METASTATIC LESIONS IN LIVER
• Amoebic liver abscess- Most common extra-intestinal presentation
Samples :
I. Stool ( 3 consecutive samples)
II. Biopsy material from the ulcers (colonoscopy or
sigmoidoscopy)
III. Aspirate from liver abscess
LABORATORY
DIAGNOSIS
• For amoebic liver abscess and other
metastatic lesions-
I. Radiological examination
II. Radio isotope tracing of liver
III. Ultrasonogrphy of upper
abdomen
IV. CT and MRI abdomen
TREATMENT
• Symptomatic case:- (amoebic colitis and amoebic
liver abscess)
750mg(adult) 5-10
Metronidazole tid Oral/iv
30mg/kg(children) days
TREATMENT
• Luminal infections and -(with above)
5-10
Parmomycin 30mg/kg qid oral
days
650mg(adult), 30-
Didohydroxyquin tid oral 20 days
40mg/kg(children)
a. Early diagnosis
b. Treatment